Could Mass Spec Overcome the CAR T Solid Tumor Barrier?
April 1, 2026
Joey Sheff explains how proteomics is revealing targets, guiding CAR design, and predicting function in solid tumors.
6 min read
False
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
All the latest Medicine Maker articles.
April 3, 2026
New review maps how engineered regulatory T cells could calm brain inflammation in Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis
1 min read
April 2, 2026
Population-wide editing system strips resistance genes – even inside hard-to-treat biofilms
2 min read
April 1, 2026
Joey Sheff explains how proteomics is revealing targets, guiding CAR design, and predicting function in solid tumors.
6 min read
April 1, 2026
A three-step engineering strategy generates vast numbers of potent NK immune cells – potentially slashing the cost and scaling of cancer immunotherapy
1 min read
March 31, 2026
New Shanghai manufacturing base and innovation center will support CAR-T production and a broader UK-China life sciences collaboration
1 min read
March 30, 2026
From capital scarcity to clinical impact, execution and partnerships are redefining the industry’s next chapter.
5 min read
March 30, 2026
New framework combining LCA and network analysis reveals hidden leverage points for decarbonization in complex drug supply networks
1 min read
March 30, 2026
In vivo gene editing strategy generates CAR T cells directly inside the body – sidestepping costly manufacturing
1 min read
March 27, 2026
New study indicates that mRNA therapy can restore fertility and sperm production in previously infertile mice
2 min read
March 26, 2026
SHED cells show early promise as a potential regenerative therapy in cerebral palsy research
2 min read
False